Z-0752-2021 Class II Terminated

Recalled by Roche Diagnostics Operations, Inc. — Indianapolis, IN

FDA device recall Z-0752-2021 was initiated by Roche Diagnostics Operations, Inc. on Nov 23, 2020 and is designated Class II. Reason for recall: During the subsequent pipetting (1st or 2nd measurement), the residual reagent can sporadically be transferred from the conus into the reaction cuvette and lead to inaccurately low results for the… The recall status is terminated (terminated Jul 6, 2023). Affected quantity: 152 kits and 7 units.

Recall details

Product Type
Devices
Report Date
Jan 6, 2021
Initiation Date
Nov 23, 2020
Termination Date
Jul 6, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
152 kits and 7 units

Product description

cobas pro integrated solutions -cobas c 503, Analyzer, chemistry (photometric discrete), for clinical use

Reason for recall

During the subsequent pipetting (1st or 2nd measurement), the residual reagent can sporadically be transferred from the conus into the reaction cuvette and lead to inaccurately low results for the affected TDMs (Therapeutic Drug Monitoring).

Distribution pattern

Domestic: IL, FL, GA, WV

Code information

Catalog Number 08445605190 08445567190 08253153190 08058580190

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0752-2021
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Roche Diagnostics Operations, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-0752-2021. Report a data issue: hello@regdatalab.com.